Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE

Alok A. Khorana, Jeffrey S. Berger, Philip S. Wells, Roger Seheult, Veronica Ashton, François Laliberté, Concetta Crivera, Dominique Lejeune, Jeff Schein, Peter Wildgoose, Patrick Lefebvre, Scott Kaatz

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1396-1408
Number of pages13
JournalClinical Therapeutics
Volume39
Issue number7
DOIs
StatePublished - Jul 1 2017

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • anticoagulant
  • extended treatment
  • recurrent
  • rivaroxaban
  • venous thromboembolism

Cite this